TECH logo

Bio-Techne Corporation (TECH) Accounts Receivable

Annual Accounts Receivable:

$206.88M-$34.52M(-14.30%)
June 30, 2025

Summary

  • As of today, TECH annual accounts receivable is $206.88 million, with the most recent change of -$34.52 million (-14.30%) on June 30, 2025.
  • During the last 3 years, TECH annual accounts receivable has risen by +$12.33 million (+6.34%).
  • TECH annual accounts receivable is now -14.30% below its all-time high of $241.39 million, reached on June 30, 2024.

Performance

TECH Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTECHbalance sheet metrics

Quarterly Accounts Receivable:

$183.90M-$22.98M(-11.11%)
September 30, 2025

Summary

  • As of today, TECH quarterly accounts receivable is $183.90 million, with the most recent change of -$22.98 million (-11.11%) on September 30, 2025.
  • Over the past year, TECH quarterly accounts receivable has dropped by -$39.79 million (-17.79%).
  • TECH quarterly accounts receivable is now -24.37% below its all-time high of $243.14 million, reached on March 31, 2025.

Performance

TECH Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTECHbalance sheet metrics

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

TECH Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-14.3%-17.8%
3Y3 Years+6.3%+5.6%
5Y5 Years+68.8%+50.0%

TECH Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-14.3%+6.3%-24.4%+5.6%
5Y5-Year-14.3%+68.8%-24.4%+50.0%
All-TimeAll-Time-14.3%+6336.7%-24.4%+2463.2%

TECH Accounts Receivable History

DateAnnualQuarterly
Sep 2025
-
$183.90M(-11.1%)
Jun 2025
$206.88M(-14.3%)
$206.88M(-14.9%)
Mar 2025
-
$243.14M(+11.6%)
Dec 2024
-
$217.94M(-2.6%)
Sep 2024
-
$223.69M(-7.3%)
Jun 2024
$241.39M(+10.5%)
$241.39M(+5.9%)
Mar 2024
-
$227.89M(+9.9%)
Dec 2023
-
$207.45M(+1.4%)
Sep 2023
-
$204.57M(-6.4%)
Jun 2023
$218.47M(+12.3%)
$218.47M(+0.9%)
Mar 2023
-
$216.41M(+17.1%)
Dec 2022
-
$184.76M(+6.1%)
Sep 2022
-
$174.17M(-10.5%)
Jun 2022
$194.55M(+33.8%)
$194.55M(-3.7%)
Mar 2022
-
$202.09M(+32.2%)
Dec 2021
-
$152.90M(+3.6%)
Sep 2021
-
$147.55M(+1.5%)
Jun 2021
$145.38M(+18.6%)
$145.38M(-7.9%)
Mar 2021
-
$157.79M(+23.0%)
Dec 2020
-
$128.24M(+4.6%)
Sep 2020
-
$122.64M(+0.1%)
Jun 2020
$122.53M(-10.9%)
$122.53M(+4.3%)
Mar 2020
-
$117.45M(+5.1%)
Dec 2019
-
$111.75M(-8.9%)
Sep 2019
-
$122.72M(-10.7%)
Jun 2019
$137.47M(+14.3%)
$137.47M(+2.6%)
Mar 2019
-
$133.93M(+18.2%)
Dec 2018
-
$113.28M(-1.3%)
Sep 2018
-
$114.75M(-4.6%)
Jun 2018
$120.30M(+3.0%)
$120.30M(+9.6%)
Mar 2018
-
$109.76M(+11.4%)
Dec 2017
-
$98.50M(-8.2%)
Sep 2017
-
$107.33M(-8.1%)
Jun 2017
$116.83M(+25.1%)
$116.83M(-1.3%)
Mar 2017
-
$118.33M(+13.4%)
Dec 2016
-
$104.37M(-5.0%)
Sep 2016
-
$109.81M(+17.6%)
Jun 2016
$93.39M(+33.4%)
$93.39M(+7.2%)
Mar 2016
-
$87.16M(+31.8%)
Dec 2015
-
$66.14M(-6.7%)
Sep 2015
-
$70.92M(+1.3%)
Jun 2015
$70.03M(+46.3%)
$70.03M(+6.3%)
Mar 2015
-
$65.89M(+15.2%)
Dec 2014
-
$57.21M(-6.0%)
Sep 2014
-
$60.87M(+27.1%)
Jun 2014
$47.87M(+25.4%)
$47.87M(-1.3%)
Mar 2014
-
$48.50M(+26.6%)
Dec 2013
-
$38.31M(-9.3%)
Sep 2013
-
$42.24M(+10.6%)
Jun 2013
$38.18M(+7.1%)
$38.18M(+0.1%)
Mar 2013
-
$38.14M(+18.5%)
Dec 2012
-
$32.19M(-8.3%)
Sep 2012
-
$35.12M(-1.5%)
Jun 2012
$35.67M(-0.7%)
$35.67M(-8.8%)
Mar 2012
-
$39.11M(+20.9%)
Dec 2011
-
$32.35M(-5.1%)
Sep 2011
-
$34.09M(-5.1%)
Jun 2011
$35.91M(+16.4%)
$35.91M(+1.0%)
Mar 2011
-
$35.55M(+26.0%)
Dec 2010
-
$28.23M(-9.0%)
Sep 2010
-
$31.02M(+0.5%)
Jun 2010
$30.85M
$30.85M(+17.9%)
DateAnnualQuarterly
Dec 2009
-
$26.16M(-13.8%)
Sep 2009
-
$30.33M(+2.8%)
Jun 2009
$29.52M(-7.0%)
$29.52M(-6.6%)
Mar 2009
-
$31.59M(+27.1%)
Dec 2008
-
$24.85M(-23.0%)
Sep 2008
-
$32.30M(+1.7%)
Jun 2008
$31.75M(+7.4%)
$31.75M(-3.2%)
Mar 2008
-
$32.80M(+12.0%)
Dec 2007
-
$29.27M(-4.6%)
Sep 2007
-
$30.67M(+3.8%)
Jun 2007
$29.56M(+24.4%)
$29.56M(-0.1%)
Mar 2007
-
$29.58M(+29.0%)
Dec 2006
-
$22.92M(-6.3%)
Sep 2006
-
$24.47M(+2.9%)
Jun 2006
$23.77M(+7.8%)
$23.77M(-8.7%)
Mar 2006
-
$26.02M(+23.8%)
Dec 2005
-
$21.02M(-6.4%)
Sep 2005
-
$22.46M(+1.9%)
Jun 2005
$22.04M(+8.8%)
$22.04M(-4.3%)
Mar 2005
-
$23.02M(+22.5%)
Dec 2004
-
$18.80M(+0.5%)
Sep 2004
-
$18.71M(-7.6%)
Jun 2004
$20.26M(+10.2%)
$20.26M(-1.5%)
Mar 2004
-
$20.56M(+21.3%)
Dec 2003
-
$16.95M(-5.3%)
Sep 2003
-
$17.90M(-2.6%)
Jun 2003
$18.39M(+8.7%)
$18.39M(-1.9%)
Mar 2003
-
$18.73M(+26.0%)
Dec 2002
-
$14.87M(-11.1%)
Sep 2002
-
$16.71M(-1.2%)
Jun 2002
$16.91M(+6.4%)
$16.91M(-1.4%)
Mar 2002
-
$17.15M(+17.5%)
Dec 2001
-
$14.60M(-11.1%)
Sep 2001
-
$16.41M(+3.2%)
Jun 2001
$15.89M(+1.9%)
$15.89M(+5.0%)
Mar 2001
-
$15.14M(-1.5%)
Dec 2000
-
$15.38M(-1.0%)
Sep 2000
-
$15.55M(-0.4%)
Jun 2000
$15.60M(+15.4%)
$15.60M(+4.4%)
Mar 2000
-
$14.94M(+13.9%)
Dec 1999
-
$13.12M(-3.7%)
Sep 1999
-
$13.62M(+0.7%)
Jun 1999
$13.52M(+35.2%)
$13.52M(-0.9%)
Mar 1999
-
$13.64M(+11.1%)
Dec 1998
-
$12.28M(-5.5%)
Sep 1998
-
$12.99M(+29.9%)
Jun 1998
$10.00M(+9.7%)
$10.00M(-2.3%)
Mar 1998
-
$10.24M(+16.8%)
Dec 1997
-
$8.77M(-3.5%)
Sep 1997
-
$9.09M(-0.3%)
Jun 1997
$9.11M(+8.8%)
$9.11M(+0.5%)
Mar 1997
-
$9.07M(+20.0%)
Dec 1996
-
$7.55M(-6.6%)
Sep 1996
-
$8.09M(-3.5%)
Jun 1996
$8.38M(+13.5%)
$8.38M(-1.3%)
Mar 1996
-
$8.49M(+16.0%)
Dec 1995
-
$7.31M(-6.9%)
Sep 1995
-
$7.86M(+6.4%)
Jun 1995
$7.39M(+12.0%)
$7.39M(+2.9%)
Mar 1995
-
$7.17M
Jun 1994
$6.59M(+37.6%)
-
Jun 1993
$4.79M(+49.1%)
-
Jun 1992
$3.21M
-

FAQ

  • What is Bio-Techne Corporation annual accounts receivable?
  • What is the all-time high annual accounts receivable for Bio-Techne Corporation?
  • What is Bio-Techne Corporation annual accounts receivable year-on-year change?
  • What is Bio-Techne Corporation quarterly accounts receivable?
  • What is the all-time high quarterly accounts receivable for Bio-Techne Corporation?
  • What is Bio-Techne Corporation quarterly accounts receivable year-on-year change?

What is Bio-Techne Corporation annual accounts receivable?

The current annual accounts receivable of TECH is $206.88M

What is the all-time high annual accounts receivable for Bio-Techne Corporation?

Bio-Techne Corporation all-time high annual accounts receivable is $241.39M

What is Bio-Techne Corporation annual accounts receivable year-on-year change?

Over the past year, TECH annual accounts receivable has changed by -$34.52M (-14.30%)

What is Bio-Techne Corporation quarterly accounts receivable?

The current quarterly accounts receivable of TECH is $183.90M

What is the all-time high quarterly accounts receivable for Bio-Techne Corporation?

Bio-Techne Corporation all-time high quarterly accounts receivable is $243.14M

What is Bio-Techne Corporation quarterly accounts receivable year-on-year change?

Over the past year, TECH quarterly accounts receivable has changed by -$39.79M (-17.79%)
On this page